Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 2
1953 1
1959 2
1963 1
1966 3
1967 1
1968 4
1969 1
1970 2
1971 2
1972 4
1974 1
1975 2
1976 1
1977 1
1978 2
1979 1
1980 3
1981 1
1982 1
1983 4
1984 3
1985 3
1986 3
1987 4
1988 2
1989 3
1990 2
1991 1
1992 2
1993 5
1994 7
1995 13
1996 5
1997 9
1998 5
1999 9
2000 6
2001 5
2002 6
2003 8
2004 7
2005 10
2006 11
2007 6
2008 10
2009 9
2010 6
2011 8
2012 6
2013 11
2014 7
2015 16
2016 7
2017 12
2018 13
2019 34
2020 30
2021 24
2022 23
2023 13
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Results by year

Filters applied: . Clear all
Page 1
Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma: Outcomes and Definition Variances in High-Risk Rb.
Arazi M, Baum A, Casavilca-Zambrano S, Alarcon-Leon S, Diaz-Coronado R, Ahmad A, Mushtaq A, Hussain M, Ushakova T, Yuri S, Vladimir P, Shields CL, Eagle RC Jr, Berry JL, Pike S, Brown B, Roy SR, Huque F, Fabian I, Frenkel S, Eiger-Moscovich M, Pe'er J, Hubbard GB 3rd, Olson TA, Grossniklaus H, Reddy MA, Sagoo MS, Staffieri SE, Elder JE, McKenzie JD, Tanabe M, Kaliki S, Fabian ID. Arazi M, et al. Among authors: baum a. Am J Ophthalmol. 2024 Sep 25:S0002-9394(24)00450-1. doi: 10.1016/j.ajo.2024.09.023. Online ahead of print. Am J Ophthalmol. 2024. PMID: 39332513
Zongertinib (BI 1810631), an irreversible HER2 TKI, spares EGFR signaling and improves therapeutic response in preclinical models and patients with HER2-driven cancers.
Wilding B, Woelflingseder L, Baum A, Chylinski K, Vainorius G, Gibson N, Waizenegger IC, Gerlach D, Augsten M, Spreitzer F, Shirai Y, Ikegami M, Tilandyova S, Scharn D, Pearson MA, Popow J, Obenauf AC, Yamamoto N, Kondo S, Opdam FL, Bruining A, Kohsaka S, Kraut N, Heymach JV, Solca F, Neumuller RA. Wilding B, et al. Among authors: baum a. Cancer Discov. 2024 Sep 9. doi: 10.1158/2159-8290.CD-24-0306. Online ahead of print. Cancer Discov. 2024. PMID: 39248702
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial.
Isa F, Gonzalez Ortiz AM, Meyer J, Hamilton JD, Olenchock BA, Brackin T, Ganguly S, Forleo-Neto E, Faria L, Heirman I, Marovich M, Hutter J, Polakowski L, Irvin SC, Thakur M, Hooper AT, Baum A, Petro CD, Fakih FA, McElrath MJ, De Rosa SC, Cohen KW, Williams LD, Hellman CA, Odeh AJ, Patel AH, Tomaras GD, Geba GP, Kyratsous CA, Musser B, Yancopoulos GD, Herman GA; Trial Working Group. Isa F, et al. Among authors: baum a. Lancet Infect Dis. 2024 Sep 2:S1473-3099(24)00421-3. doi: 10.1016/S1473-3099(24)00421-3. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39236733
Genetic risk factors for COVID-19 and influenza are largely distinct.
Kosmicki JA, Marcketta A, Sharma D, Di Gioia SA, Batista S, Yang XM, Tzoneva G, Martinez H, Sidore C, Kessler MD, Horowitz JE, Roberts GHL, Justice AE, Banerjee N, Coignet MV, Leader JB, Park DS, Lanche R, Maxwell E, Knight SC, Bai X, Guturu H, Baltzell A, Girshick AR, McCurdy SR, Partha R, Mansfield AJ, Turissini DA, Zhang M, Mbatchou J, Watanabe K, Verma A, Sirugo G; Colorado Center for Precision Medicine; Mayo Clinic Project Generation; Regeneron Genetics Center; University of California Los Angeles ATLAS Collaboration; Ritchie MD, Salerno WJ, Shuldiner AR, Rader DJ, Mirshahi T, Marchini J, Overton JD, Carey DJ, Habegger L, Reid JG, Economides A, Kyratsous C, Karalis K, Baum A, Cantor MN, Rand KA, Hong EL, Ball CA, Siminovitch K, Baras A, Abecasis GR, Ferreira MAR. Kosmicki JA, et al. Among authors: baum a. Nat Genet. 2024 Aug;56(8):1592-1596. doi: 10.1038/s41588-024-01844-1. Epub 2024 Aug 5. Nat Genet. 2024. PMID: 39103650 Free PMC article.
Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics.
Lee HN, Xu B, Lewkowicz AP, Engel K, Kelley-Baker L, McWilliams IL, Ireland DDC, Kielczewski JL, Li J, Fariss RN, Campos MM, Baum A, Kyratsous C, Pascal K, Chan CC, Caspi RR, Manangeeswaran M, Verthelyi D. Lee HN, et al. Among authors: baum a. EBioMedicine. 2024 Jun;104:105170. doi: 10.1016/j.ebiom.2024.105170. Epub 2024 Jun 1. EBioMedicine. 2024. PMID: 38823088 Free PMC article.
Comparison of Self and Caregiver Reports of Antiretroviral Treatment Adherence among Children and Adolescents Living with HIV in Western Kenya.
Gillette E, Nyandiko W, Baum A, Chory A, Aluoch J, Ashimosi C, Lidweye J, Njorge T, Sang F, Nyagaya J, Scanlon M, Vreeman R. Gillette E, et al. Among authors: baum a. J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241242335. doi: 10.1177/23259582241242335. J Int Assoc Provid AIDS Care. 2024. PMID: 38562058 Free PMC article.
Unveiling peripheral neuropathy and cognitive dysfunction in diabetes: an observational and proof-of-concept study with video games and sensor-equipped insoles.
Ming A, Lorek E, Wall J, Schubert T, Ebert N, Galatzky I, Baum AK, Glanz W, Stober S, Mertens PR. Ming A, et al. Among authors: baum ak. Front Endocrinol (Lausanne). 2024 Mar 1;15:1310152. doi: 10.3389/fendo.2024.1310152. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38495786 Free PMC article.
387 results